1 / 6

Proteomics Market Expected to Reach $72,444 Million by 2025

global proteomics market was valued at $24,361million in 2017, and is expected to reach $72,444 million by 2025, growing at a CAGR of 14.5% during the forecast period.

newmarketindustry
Télécharger la présentation

Proteomics Market Expected to Reach $72,444 Million by 2025

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Proteomics Market

  2. Proteomics has the capacity to explain questions that were unsolved by genomics, as proteins are the functional unit of cells. Advancements in technologies, such as mass spectrometry and chromatography, and development of computer algorithms for database searching facilitate proteomics research. The analysis of target proteins for drug discovery is the largest application of proteomics. ,"Global Proteomics Market was valued at $24,361 million in 2017, and is projected to reach $72,444 million by 2025, growing at a CAGR of 14.5% from 2018 to 2025. The instruments segment is expected to dominate the global market throughout the forecast period. North America held the leading position in the global market in 2017, and is expected to maintain this trend until 2025. Get Sample Report

  3. Proteomics is the study of proteins, particularly their function and structure on a large scale. It is a remarkable approach for studying dynamic changes in metabolism in response to diverse stress conditions. The key drivers of the global proteomics market include increased R&D funding by leading players and government agencies, such as National Institutes of Health (NIH) and National Science Foundation (NSF), technological advancements, such as development of dual mass analyzers (for instance LC/MS, GC/MS, FT-MS, and MALDI-TOF/TOF), and improvements in the liquid chromatography & gel electrophoresis procedures. Moreover, increase in popularity of personalized medicines is expected to propel the proteomics market growth. However, high cost of instruments and dearth of skilled researchers hamper the market growth.

  4. The global proteomics market is segmented based on component, application, and region. On the basis of component, the market is categorized into reagents, instruments, and services. The reagents segment is further classified into microarray, spectrometry, X-ray crystallography, chromatography, electrophoresis, immunoassay, and protein fractionation reagents. Likewise, the proteomics instruments segment is subsegmented into protein microarray, spectrometry, chromatography, electrophoresis, surface plasmon resonance, X-ray crystallography, and protein fractionation systems. The spectrometry segment is subdivided into mass spectrometry and NMR spectrometry. Likewise, the chromatography segment is subclassified into HPLC systems, ion chromatography, affinity chromatography, and supercritical fluid chromatography.

  5. Key Findings of the Proteomics Market: • The reagents segment generated the highest revenue in 2017, and is projected to grow at a CAGR of 14.0% during the forecast period. • The instruments segment is anticipated to grow at the highest CAGR throughout the forecast period. • Drug discovery application dominated the global proteomics market share in 2017, accounting for nearly three-fifths of the proteomics market size in 2017. • In 2017, the U.S. was the leading country, occupying the largest market share in the global proteomics market.

  6. North America held the largest proteomics market size of nearly two-fifths share of the total market in 2017, due to increase in popularity and adoption of personalized medicines and favorable government funding & initiatives to develop novel therapeutics. However, Asia-Pacific is expected to grow at a CAGR of 16.8% from 2018 to 2025, owing to rise in prevalence of chronic diseases and increase in interest of researchers to utilize proteomics in disease diagnosis & treatment.

More Related